Showing results (531-540 of 2,733) with videos related to

Sort By:
Pageof 274
Pharmacogenomics|January 20, 2023
Application of next-generation sequencing in diffuse large B-cell lymphomaYudi Wang, Suzhen Jia, Xiubo Cao, et al.
Pharmacogenomics|January 7, 2021
Patients carrying DPYD variant alleles have increased risk of severe toxicity and related treatment modifications during fluoropyrimidine chemotherapyFaisal Shakeel, Fang Fang, Jung Won Kwon, et al.
Pharmacogenomics|June 2, 2021
Genetic variants of PEAR1 and ischemic clinical outcomes in coronary artery disease patients: a systematic review and meta-analysisXinyi Zhang, Sicong Li, Yuxuan Zhao, et al.
Pharmacogenomics|June 8, 2021
Gender-dependent association of TYMS-TSER polymorphism with 5-fluorouracil or capecitabine-based chemotherapy toxicityCharalampia Ioannou, Georgia Ragia, Ioanna Balgkouranidou, et al.
Pharmacogenomics|December 7, 2022
SLCO1B3 T334G polymorphisms and mycophenolate mofetil-related adverse reactions in kidney transplant recipientsJianxun Zhong, Kun Yang, Mi Zhang, et al.
Pharmacogenomics|June 8, 2022
The pharmacogenomics of selective serotonin reuptake inhibitorsLuis M García-Marín, Jill A Rabinowitz, Zuriel Ceja, et al.
Pharmacogenomics|September 24, 2020
Liver enzyme CYP2D6 gene and tardive dyskinesiaJustin Y Lu, Arun K Tiwari, Natalie Freeman, et al.
Pharmacogenomics|December 11, 2020
Pharmacogenetics of inflammatory bowel diseaseBianca Jc van den Bosch, Marieke Jh Coenen
Pharmacogenomics|October 30, 2020
Pharmacogenetics of TNF inhibitor response in rheumatoid arthritis utilizing the two-component disease activity scoreSyed Sa Gilani, Nisha Nair, Darren Plant, et al.
Pharmacogenomics|October 30, 2020
High prevalence of CYP2D6 ultrarapid metabolizers in a mestizo Colombian population in relation to Hispanic mestizo populationsAlba P Sarmiento, Pedro Dorado, Angélica Borbón, et al.
Pageof 274